Cell Culture Market Worth $48.63 Billion by 2029

According to a new market research report titled, ‘Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) – Global Forecast to 2029,’ published by Meticulous Research®, the cell culture market is expected to grow at a CAGR of 11.7% from 2022 to 2029, to reach $48.63 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

A major factor contributing to the growth of this market is the increasing prevalence of chronic diseases. Hence, research studies are carried out for the treatment of these diseases. The drug development-related research studies involve cell culture techniques. Furthermore, the aging population increases the chances of age-related chronic diseases, further driving the market growth.

Additionally, there has been an increase in the adoption of single-use technology due to its advantages compared to other conventional technology, such as pre-sterilized condition, no post-process cleaning of the system, and less contamination. These factors further propel the demand for cell culture products.

Additionally, the growing adoption of 3D cell culture and the growth potential of personalized medicine are expected to offer significant growth opportunities for the players operating in the cell culture market.

The cell culture market is segmented by product [consumables (media {cell culture media, by physical form–dry powder media, liquid media}, {cell culture media, by type–off-the-shelf media, custom media}, {cell culture media; source-chemically defined media, serum-free media, classical media, xeno-free/animal component free, other cell culture media}), reagents (growth factors and cytokines, cryoprotective reagents, antibiotics/ antimycotics, cell dissociation reagents, buffers, balanced salt solutions, attachment and matrix factors, other cell culture reagents), cells and cell lines, sera (fetal bovine serum, other sera), cell culture vessels (cell culture dishes, cell culture plates, cell culture flasks, roller bottles, other cell culture vessels)) equipment (cryopreservative containers, refrigerators and freezers, biosafety cabinets, incubators, sterilizers, bioreactors, microscopes, centrifuges, cell counters, water baths, other equipment)]; application [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, cell and gene therapy)], diagnostics, cancer research, drug screening and development, stem cell research); end user (pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories); and geography (North America, Europe, Asia-Pacific, Latin America, and MEA). The study also evaluates industry competitors and analyzes their market shares at country and regional levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4788

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The segment is also expected to register the highest CAGR during the forecast period. The major factor contributing to the segment’s lucrative growth is the adoption of cell culture techniques for various applications in the life science sectors such as cancer research, stem cell research, bioproduction, and diagnosis. Hence, the recurrent use of consumables for research studies and production facilities.

Based on application, the bioproduction segment is expected to register the highest CAGR during the forecast period. Bioproduction includes monoclonal antibody production, therapeutic protein production, vaccine production, and cell and gene therapy. These applications are gaining popularity due to their effectiveness in treating diseases. Moreover, vaccine production was at a higher rate during the pandemic. Due to their effectiveness, an increase in approvals for monoclonal antibodies was also observed during the pandemic, contributing to the growth of this segment.

Quick Buy – Cell Culture Market Research Report: https://www.meticulousresearch.com/Checkout/94004198

Based on end user, the pharmaceutical and biotechnology companies segment is expected to register the highest growth rate during the forecast period. The major factor contributing to the growth of this segment is the rise in R&D spending of these companies for drug discovery and developments, vaccine production, and cancer cells. Additionally, these companies use cell culture products to produce biomolecules, further leading to market growth.

Based on geography, Asia-Pacific is expected to register the highest growth rate during the forecast period. Major factors contributing to the growth of this segment are the expansion of the biopharma and pharma companies in the region, an increase in the funding for research studies, and the growing number of clinical research activities.

Some of the key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmbH (Germany).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/cell-culture-market-4788

Scope of the Report:

Cell Culture Market, by Product

• Consumables
  • Media
    • Cell Culture Media Market, by Physical Form
      • Dry Powder Media
      • Liquid Media
    • Cell Culture Media Market, by Type
      • Off-the-Shelf Media
      • Custom Media
    • Cell Culture Media Market, by Source
      • Chemically Defined Media
      • Serum-free Media
      • Classical Media
      • Xeno-free/Animal Component Free
      • Other Cell Culture Media
  • Reagents
    • Growth Factors and Cytokines
    • Cryoprotective Reagents
    • Antibiotics/ Antimycotics
    • Cell Dissociation Reagents
    • Buffers
    • Balanced Salt Solutions
    • Attachment and Matrix Factors
    • Other Cell Culture Reagents

                    (Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)

• • Cells and Cell Lines
  • Sera
    • Fetal Bovine Serum
    • Other Sera

                    (Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)

• • Cell Culture Vessels
    • Cell Culture Dishes
    • Cell Culture Plates
    • Cell Culture Flasks
    • Roller Bottles
    • Other Cell Culture Vessels

                    (Other cell culture vessels include pipettes, tips, cuvettes, and tubings)

• Equipment
  • Cryopreservative Containers
  • Refrigerators and Freezers
  • Biosafety Cabinets
  • Incubators
  • Sterilizers
  • Bioreactors
  • Microscopes
  • Centrifuges
  • Cell Counters
  • Water Baths
  • Other Equipment

               (Other equipment includes scales, weighing balance, and pH meter)

Cell Culture Market, by Application

• Bioproduction
  • Monoclonal Antibody Production
  • Therapeutic Protein Production
  • Vaccine Production
  • Cell and Gene therapy
• Diagnostics
• Cancer Research
• Drug Screening and Development
• Stem Cell Research

Cell Culture Market, by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Laboratories

Cell Culture Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

Diabetes Care Devices Market Worth $31.9 Billion by 2028 – Exclusive Report by Meticulous Research®

 According to a new market research report, titled “Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] – Global Forecast to 2028” published by Meticulous Research®, the diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

As the prevalence of diabetes is increasing globally, self-management of diabetic treatments has become necessary to avoid long-term complications and fatalities. Diabetes care devices play an important role in managing diabetes as they enable patients to record and track their blood glucose levels all day long and administer the insulin doses according to the insulin levels.

The key factors driving the overall diabetes care devices market are the rising obesity cases, unhealthy and sedentary lifestyle, increasing prevalence of diabetes, and development of new insulin delivery systems. However, some limitations of diabetes care devices are their high costs and accessibility in low-middle income countries.

Impact of COVID-19 on Diabetes Care Devices Market

The COVID-19 pandemic has severely impacted the diabetes care devices market. COVID-19 patients had higher blood glucose levels due to the use of steroids for the COVID-19 treatment. In 2020, the increase in the number of individuals suffering from diabetes due to COVID-19 expanded the income of the central participants in the diabetes care division. Many players in the market presented new progressed diabetes care devices and association arrangements for diabetes care devices.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3438

Diabetes Care Devices Market Overview

The diabetes care devices market is segmented based on type: (diabetes monitoring devices and insulin delivery devices) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).  The study also evaluates industry competitors and analyzes their market share at a global level.

In 2021, the diabetes monitoring devices segment is estimated to account for the largest share of the overall diabetes care devices market. This is mainly attributed to the increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness towards the disease in developing countries. Diabetes monitoring devices can be utilized to monitor blood glucose values and help the patient adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a regular basis.

Diabetes monitoring devices are further segmented into continuous blood glucose monitoring devices, test strips, lancets, self-monitoring blood glucose meters, and hemoglobin A1C testing kits. The test strips segment is expected to dominate the diabetes monitoring devices market in 2021, primarily due to the frequent usage of test strips for both continuous and self-glucose monitoring and is widely used by patients in developing countries.

Moreover, insulin delivery devices also are further segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. In 2021, the insulin pens segment is expected to dominate the insulin delivery devices market. This can be primarily attributed to its advantages over traditional syringe insulin delivery methods, including improved patient satisfaction and adherence, user-friendly, greater ease of use, superior accuracy for delivering small insulin doses, greater social acceptability, and less reported injection pain. However, insulin pumps are the fastest-growing segment due to the advantages such as predictable insulin delivery, precise delivery of insulin, and reduction of wide fluctuation in blood glucose. It also mimics the normal pancreas’s release of insulin.

Quick Buy – Diabetes Care Devices Market Research Report: https://www.meticulousresearch.com/Checkout/33395503

Geographically, in 2021, North America is estimated to account for the largest share of the global diabetes care devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of diabetes with the rising need to self-monitor and treat the disease, increasing prevalence of major risk factors of diabetes such as obesity and sedentary lifestyle, increasing geriatric population, and growing government initiatives promoting diabetes care are driving the growth of the diabetes care devices market in North America. However, Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is expected to be driven by the increasing prevalence of diabetes with the rising need to self-monitor the treatments, increasing prevalence of obesity and sedentary lifestyle, growing geriatric population, and government initiatives promoting diabetes care.

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past four years. In recent years, the diabetes care devices market has witnessed several new product launches, approvals, agreements, collaborations, partnerships, expansions, and acquisitions. For instance, in May 2021, Medtronic PLC (Ireland) received CE Mark approval for the expanded functionality of its InPen and Guardian 4 sensors. Moreover, in February 2020, Abbott Laboratories (U.S.) partnered with Insulet Corporation (U.S.) to combine its leading continuous glucose monitoring (CGM) technology with Insulet’s Omnipod Horizon Automated Insulin Delivery System.

Some of the key players operating in the global diabetes care devices market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi AS (France), and DexCom, Inc. (U.S.), among others.

The diabetes care devices market is dominated by Abbott Laboratories (U.S.), Medtronic PLC (Ireland), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Ascensia Diabetes Care (Switzerland), LifeScan IP Holding, LLC (U.S.), Becton, Dickinson and Company (U.S.), Insulet Corporation (U.S.), Novo Nordisk A/S (Denmark), and Tandem Diabetes Care, Inc. (U.S.). Together, these companies held around 80% share of the global diabetes care devices market in 2020.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/diabetes-care-devices-market-3438

Scope of the Report:

Diabetes Care Devices Market, by Type

• Diabetes Monitoring Devices
• Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438